These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29095735)

  • 1. Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation.
    Aburjania N; Ertmer BM; Farid S; Berg M; Nienaber JJC; Tchantchaleishvili V; Stulak JM; Baddour LM; Sohail MR
    ASAIO J; 2018; 64(6):735-740. PubMed ID: 29095735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus multi-drug antimicrobial surgical infection prophylaxis for left ventricular assist devices: A systematic review and meta-analysis.
    Patel S; Choi JH; Moncho Escrivá E; Rizvi SSA; Maynes EJ; Samuels LE; Luc JGY; Morris RJ; Massey HT; Tchantchaleishvili V; Aburjania N
    Artif Organs; 2019 Jul; 43(7):E124-E138. PubMed ID: 30810232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical infection prophylaxis for left ventricular assist device implantation.
    Walker PC; DePestel DD; Miles NA; Malani PN
    J Card Surg; 2011 Jul; 26(4):440-3. PubMed ID: 21554393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
    Mourad A; Arif S; Bishawi M; Milano C; Miller RA; Maskarinec SA
    J Card Surg; 2020 Oct; 35(10):2672-2678. PubMed ID: 32678965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
    Allen L; Bartash R; Minamoto GY; Cowman K; Patel S; Vukelic S; Nnani DU; Fauvel D; Guo Y
    Transpl Infect Dis; 2022 Oct; 24(5):e13900. PubMed ID: 35785460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
    Jennings DL; Chopra A; Chambers R; Morgan JA
    Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and prognostic impact of left ventricular assist device-associated infections.
    Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
    Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.
    Cho SM; Moazami N; Katz S; Bhimraj A; Shrestha NK; Frontera JA
    Neurocrit Care; 2019 Aug; 31(1):72-80. PubMed ID: 30644037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Assist Device: Review of Antimicrobial Prophylaxis Strategies and Incidence of Infections at a Tertiary Care Center 12-Year Experience.
    Mendoza MA; Ranganath N; Garcia BB; Stevens RW; Lahr B; O'Horo J; Stulak J; Shah A
    Open Forum Infect Dis; 2023 Sep; 10(9):ofad465. PubMed ID: 37732167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device.
    Hieda M; Sata M; Seguchi O; Yanase M; Murata Y; Sato T; Sunami H; Nakajima S; Watanabe T; Hori Y; Wada K; Hata H; Fujita T; Kobayashi J; Nakatani T
    Transplant Proc; 2014 Apr; 46(3):907-10. PubMed ID: 24767378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Galand V; Flécher E; Auffret V; Boulé S; Vincentelli A; Dambrin C; Mondoly P; Sacher F; Nubret K; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Verdonk C; Ghodbane W; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Radu C; Pierre B; Bourguignon T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Verhoye JP; Leclercq C; Martins RP;
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1166-1175. PubMed ID: 30236390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device-related infections: does the time of onset matter?
    Lehnert AL; Hart A; Brouse SD; Charnigo RJ; Branam S; Guglin ME
    J Artif Organs; 2019 Jun; 22(2):98-103. PubMed ID: 30386926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.